Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Programmed cell death in amyotrophic lateral sclerosis
Christelle Guégan, Serge Przedborski
Christelle Guégan, Serge Przedborski
Published January 15, 2003
Citation Information: J Clin Invest. 2003;111(2):153-161. https://doi.org/10.1172/JCI17610.
View: Text | PDF
Perspective

Programmed cell death in amyotrophic lateral sclerosis

  • Text
  • PDF
Abstract

Authors

Christelle Guégan, Serge Przedborski

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Molecular pathways of PCD. To date, at least three different PCD molecul...
Molecular pathways of PCD. To date, at least three different PCD molecular pathways have been recognized: the mitochondrial pathway (also called intrinsic), the death receptor pathway (also called extrinsic), and the ER pathway. In the mitochondrial PCD pathway, translocation of the proapoptotic protein Bax and the BH3-domain-only protein Bid from the cytosol to the mitochondria promotes cell death by inducing the release of cytochrome c (Cyt. c)from the mitochondria to the cytosol; although both full-length and truncated Bid (t-Bid) translocate to the mitochondria, t-Bid is the most biologically active form. Once in the cytosol, cytochrome c activates caspase-9 in the presence of Apaf-1, which, in turn, activates downstream executioner caspases. This pathway can be inhibited by the antiapoptotic protein Bcl-2 and by the protein caspase inhibitor X chromosome–linked inhibitor of apoptosis (XIAP). In the death receptor pathway, caspase-8 is activated by death receptors (members of the TNFR family) in the plasma membrane via the intermediary of adapter proteins. Death receptors include Fas (CD95) and the low-affinity neurotrophin receptor (p75NTR). Activated caspase-8 then activates executioner caspases, directly or indirectly, through the activation of Bid. Stress in the ER, including disruption of ER-calcium homeostasis and accumulation of excess proteins in the ER, can also result in apoptosis through activation of caspase-12. This caspase is not activated by membrane- or mitochondria-targeted apoptotic signals. Activation of the upstream caspase-1, the key enzyme responsible for the activation of IL-1, also results in activation of executioner caspases and enhances, at least in part through the cleavage of Bid, the activation of the mitochondria-dependent apoptotic pathway.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts